![](https://1abmedia.com/wp-content/uploads/2023/05/logo-abdera.jpg)
![](https://1abmedia.com/wp-content/uploads/2024/03/logo-acelryn-1.jpg)
![](https://1abmedia.com/wp-content/uploads/2023/09/actio-logo.png)
![](https://1abmedia.com/wp-content/uploads/2023/03/aera-logo.jpg)
![](https://1abmedia.com/wp-content/uploads/2022/07/logo-agios.jpg)
![](https://1abmedia.com/wp-content/uploads/2022/03/logo-alector.jpg)
![](https://1abmedia.com/wp-content/uploads/2023/09/apogee.jpg)
![](https://1abmedia.com/wp-content/uploads/2018/12/beam.png)
![](https://1abmedia.com/wp-content/uploads/2023/05/logo-bicara.jpg)
![](https://1abmedia.com/wp-content/uploads/2023/05/logo-boundlessbio.jpg)
![](https://1abmedia.com/wp-content/uploads/2021/10/bridgebio.jpg)
![](https://1abmedia.com/wp-content/uploads/2022/03/logo-celldex.jpg)
![](https://1abmedia.com/wp-content/uploads/2023/03/Curie-Logo.jpg)
![](https://1abmedia.com/wp-content/uploads/2021/03/ensoma.png)
![](https://1abmedia.com/wp-content/uploads/2024/03/logo-function.jpg)
![](https://1abmedia.com/wp-content/uploads/2021/10/gritstonebio.jpg)
![](https://1abmedia.com/wp-content/uploads/2022/09/logo-idrx.png)
![](https://1abmedia.com/wp-content/uploads/2019/04/insitro.png)
![](https://1abmedia.com/wp-content/uploads/2021/01/logo-lifemine.jpg)
![](https://1abmedia.com/wp-content/uploads/2022/07/logo-loxo.jpg)
![](https://1abmedia.com/wp-content/uploads/2019/04/maze.png)
![](https://1abmedia.com/wp-content/uploads/2020/04/moma.png)
![](https://1abmedia.com/wp-content/uploads/2021/10/neumora.jpg)
![](https://1abmedia.com/wp-content/uploads/2022/09/logo-orbital.png)
![](https://1abmedia.com/wp-content/uploads/2022/03/logo-ovid.jpg)
![](https://1abmedia.com/wp-content/uploads/2022/07/logo-prime.jpg)
![](https://1abmedia.com/wp-content/uploads/2018/12/relay.png)
![](https://1abmedia.com/wp-content/uploads/2023/09/rezo.jpg)
![](https://1abmedia.com/wp-content/uploads/2023/05/logo-structure.jpg)
![](https://1abmedia.com/wp-content/uploads/2019/06/TRV_primary_2.png)
![](https://1abmedia.com/wp-content/uploads/2018/12/vertex.png)
![](https://1abmedia.com/wp-content/uploads/2022/07/logo-verve.jpg)
![](https://1abmedia.com/wp-content/uploads/2021/10/xiliotherapeutics.jpg)
Capabilities
- Executive Counsel
- Message Development/Refinement
- Corporate Communications
- Unparalleled Media Relations
- Executive Visibility & Speaking Opportunities
- Investor Relations & Capital Markets Advisory
- Presentation & Media Training
- Crisis Management
- Digital, Creative & Social Media Strategy
- Website & Brand Development
WE WORK WITH CLIENTS THROUGH MANY PHASES AND EXPERIENCES
- Company launches, private companies, publicly traded companies
- Financings, business development agreements, IPOs/reverse mergers, M&A
- Every phase of drug/device development, medical meeting and journal publication
- Drug/product approval (in U.S. and abroad), launch and commercial support
- Navigating various moments of adversity – clinical trial setbacks, FDA advisory committee meetings, approvable letters/CRLs, and unfortunately, many more!
STAT - ARCH Venture Partners: Q&A with Kristina Burow
The Economist: Neumora and Alector:: Better brain biology will deliver better medicines
Barron's: a16z: Healthcare Learned a Lot From Covid. 12 Ways to Invest Now.
STAT - Relay Therapeutics: Relay Therapeutics drug shows promise in early trial